发明名称 SUBSTITUTED 6,5-HETERO-BICYCLIC DERIVATIVES
摘要 PURPOSE: Provided are certain pharmaceutically active subsumed 6,5water, bicyclic derivatives, pharmaceutical compositions containing them and methods of administering them to subjects in need of their corticotropin releasing factor(CRF) antagonist activity. The substituted heterocyclic derivatives exhibit activity as corticotropin releasing factor (hormone) CRF (CRH) antagonists. CONSTITUTION: Provided are compounds of formula (I), wherein the dashed lines represent optional double bonds; A is nitrogen or CR(7); B is -NR(1)R(2), -CR(1)R(2)R(10)-C(=CR(2)R(11))R(1), -NHCR(1)R(2)R(10), -OCR(1)R(2)R(10), -SCR(1)R(2)R(10), -CR(2)R(10)NHR(1), -CR(2)R(10)OR(1), -CR(2)R(10)SR(1) or -COR(2); J and K are each independently nitrogen or carbon and both J and K are not nitrogen; D and E are each selected, independently, from nitrogen, CR(4), C=O, C=S, sulfur, oxygen, CR(4)R(6) and NR(8); G is nitrogen or carbon; and their use for the prevention or inhibition of a disorder that can be treated by antagonizing CRF.
申请公布号 KR20000035934(A) 申请公布日期 2000.06.26
申请号 KR19997001674 申请日期 1999.02.27
申请人 PFIZER 发明人 CHEN YUHPYNG LIANG
分类号 A61K31/00;A61K31/435;A61K31/4353;A61K31/437;A61K31/505;A61K31/519;A61K31/529;A61P1/00;A61P1/04;A61P1/12;A61P1/14;A61P3/00;A61P3/04;A61P3/08;A61P5/24;A61P5/42;A61P7/12;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/00;A61P13/02;A61P15/00;A61P15/06;A61P15/08;A61P17/02;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P21/00;A61P21/02;A61P25/00;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/34;A61P25/36;A61P29/00;A61P31/00;A61P31/18;A61P35/00;A61P37/00;A61P37/04;A61P37/08;A61P43/00;C07D471/04;C07D487/04;(IPC1-7):C07D487/04 主分类号 A61K31/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利